Molecule intelOpportunity: ModerateEssential

Carbimazole

7 brands · 6 companies · product forms

ATC: H03BB01

Opportunity snapshot

Launch attractiveness
44
Market saturation
16
Price room
70
Regulatory risk
0
7
brands
6
companies
Rs 280.94
median price
5
price points
3.81x
price spread
100
confidence %

Who competes here

Top companies by brand count · leader share 29%

Price room

Across observed sources and strengths
CheapestRs 78.86
MedianRs 280.94
Most expensiveRs 300.75
Spread3.81×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 3.81x across 5 trusted points (Rs 78.86-300.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Brands & products on the market

Sample of 2 live products for Carbimazole — each links to its own medicine page.

Why this score

Launch attractiveness

40% supply-gap(25) + 25% price-variation(70) + 20% low-competition(84) + 15% supply-disruption(0), damped by confidence(100). Higher = more attractive, less crowded opportunity.

Market saturation

6 canonical companies and 7 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 3.81x across 5 trusted points (Rs 78.86-300.75). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Full coverage.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.